- Evaluation of Advanced Oxidation Protein Products, Prooxidant-Antioxidant Balance, and Total Antioxidant Capacity in Untreated Vitiligo Patients
-
Guntas G, Engin B, Ekmekci OB, Kutlubay Z, Ekmekci H, Songur A, Uzuncakmak TKU, Vehid HE, Serdaroglu S, Tuzun Y, Uzun H
- KMID: 2264807
- Ann Dermatol.
- 2015 Apr;27(2):178-183.
- doi: 10.5021/ad.2015.27.2.178
BACKGROUND: Vitiligo is a chronic, common disease of unknown etiology, and oxidative stress is suggested to have a role in its etiopathogenesis. OBJECTIVE: Advanced oxidation protein products (AOPPs), prooxidant-antioxidant balance (PAB),... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Angiotensin-Converting Enzyme Polymorphism on Soluble Receptor for Advanced Glycation End-Products in Maintenance Hemodialysis Patients
-
Lee KW, Cha JM, Lee YM, Park SD, Song JH, Ahn SH
- KMID: 2267772
- Korean J Med.
- 2013 Nov;85(5):495-502.
BACKGROUND/AIMS: Advanced glycation end-products (AGEs) exert various toxic effects through the receptor for AGEs (RAGE). Soluble RAGE (sRAGE) is a naturally occurring inhibitor of AGE-RAGE. Recent studies have suggested that... -
- CITED
-
- Close
- SHARE
-
- Close
- The Factors Influencing Level of Advanced Oxidation Protein Products (AOPP) in Hemodialysis Patients
-
Cha JM, Lee KW, Lee YM, Kim HJ, Park DS, Ahn SH, Song JH
- KMID: 2253164
- Korean J Nephrol.
- 2009 Sep;28(5):444-449.
PURPOSE: Advanced oxidation protein products (AOPP) has long been considered as a useful marker to estimate oxidative stress in the hemodialysis (HD) patients. However, it has not been clarified what... -
- CITED
-
- Close
- SHARE
-
- Close
- A new biomarker for the early diagnosis of ovarian torsion: SCUBE-1
-
Uyanikoglu H, Hilali NG, Yardimciel M, Koyuncu I
- KMID: 2415105
- Clin Exp Reprod Med.
- 2018 Jun;45(2):94-99.
- doi: 10.5653/cerm.2018.45.2.94
OBJECTIVE: Prompt diagnosis and management are essential for saving the adnexal organs from infarction in cases of ovarian torsion (OT). This study aimed to determine the diagnostic significance of signal... -
- CITED
-
- Close
- SHARE
-
- Close
